{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T07:42:59Z","timestamp":1774597379000,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T00:00:00Z","timestamp":1702771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002918","name":"Gentofte Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002918","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.conctc.2023.101245","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T14:37:45Z","timestamp":1703083065000},"page":"101245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Accelerating patient recruitment using social media: Early adopter experience from a good clinical practice-monitored randomized controlled phase I\/IIa clinical trial on actinic keratosis"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9708-6717","authenticated-orcid":false,"given":"Vinzent Kevin","family":"Ortner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Zibert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olena","family":"Budnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ionela","family":"Manole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte Amalie Pind","family":"Laugesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Signe","family":"Havsager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merete","family":"Haedersdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.conctc.2023.101245_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/picr.PICR_6_20","article-title":"Recruitment and retention of participants in clinical studies: critical issues and challenges","volume":"11","author":"Desai","year":"2020","journal-title":"Perspect Clin Res"},{"issue":"11","key":"10.1016\/j.conctc.2023.101245_bib2","doi-asserted-by":"crossref","DOI":"10.2196\/22179","article-title":"Online patient recruitment in clinical trials: systematic review and meta-analysis","volume":"22","author":"Br\u00f8gger-Mikkelsen","year":"2020","journal-title":"J. Med. Internet Res."},{"issue":"10","key":"10.1016\/j.conctc.2023.101245_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061012","volume":"12","author":"Ortner","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.conctc.2023.101245_bib4","article-title":"A rejected hypothesis: phenomenon of high treatment adherence in direct-to-consumer teledermatology despite lack of direct physician-patient interaction","volume":"8","author":"Abeck","year":"2022","journal-title":"Telemed. J E-Health Off. J. Am. Telemed. Assoc. Publ. Online December"},{"issue":"3","key":"10.1016\/j.conctc.2023.101245_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.317","article-title":"Clinical trial allocation in multinational pharmaceutical companies \u2013 a qualitative study on influential factors","volume":"5","author":"Dombernowsky","year":"2017","journal-title":"Pharmacol. Res. Perspect"},{"key":"10.1016\/j.conctc.2023.101245_bib6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1186\/s13063-019-3790-9","article-title":"Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations","volume":"20","author":"Dombernowsky","year":"2019","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.conctc.2023.101245_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijwd.2016.12.001","article-title":"Clinical trials in dermatology","volume":"3","author":"Torre","year":"2017","journal-title":"Int. J. Womens Dermatol."},{"issue":"1","key":"10.1016\/j.conctc.2023.101245_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s13063-022-06144-9","article-title":"Success and failure factors of patient recruitment for industry-sponsored clinical trials and the role of the electronic health records\u2014a qualitative interview study in the Nordic countries","volume":"23","author":"Laaksonen","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.conctc.2023.101245_bib9","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v102.1057","article-title":"Ablative fractional laser-assisted low-irradiance photodynamic therapy for treatment of actinic keratoses in organ transplant recipients: a prospective, randomized, intraindividual controlled trial","volume":"102","author":"Lonsdorf","year":"2022","journal-title":"Acta Derm. Venereol."},{"issue":"2","key":"10.1016\/j.conctc.2023.101245_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.abd.2021.06.005","article-title":"Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial","volume":"97","author":"Alvares","year":"2022","journal-title":"An. Bras. Dermatol."},{"issue":"3","key":"10.1016\/j.conctc.2023.101245_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bjd.20974","article-title":"Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments)","volume":"187","author":"Hasan","year":"2022","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.conctc.2023.101245_bib12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1684\/ejd.2021.4137","article-title":"A 12-month follow-up split-scalp study comparing calcipotriol-assisted MAL-PDT with conventional MAL-PDT for the treatment of actinic keratosis: a randomized controlled trial","volume":"31","author":"Torezan","year":"2021","journal-title":"Eur. J. Dermatol. EJD"},{"issue":"5","key":"10.1016\/j.conctc.2023.101245_bib13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/phpp.12671","article-title":"Comparative study of imiquimod 3.75% vs. photodynamic therapy for actinic keratosis of the scalp","volume":"37","author":"Cortelazzi","year":"2021","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"3","key":"10.1016\/j.conctc.2023.101245_bib14","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1080\/09546634.2020.1817839","article-title":"Comparing efficacy and safety of potassium hydroxide 5% solution with 5-fluorouracil cream in patients with actinic keratoses: a randomized controlled trial","volume":"33","author":"Salehi Farid","year":"2022","journal-title":"J. Dermatol. Treat."},{"issue":"3","key":"10.1016\/j.conctc.2023.101245_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13459","article-title":"Peeling with 70% glicolic acid followed by 5% 5-fluorouracil as well as 5% 5-fluorouracil cream are effective methods for the treatment of actinic keratoses on upper limbs: a randomized clinical trial","volume":"33","author":"Heuser","year":"2020","journal-title":"Dermatol. Ther."},{"issue":"6","key":"10.1016\/j.conctc.2023.101245_bib16","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/jdv.16123","article-title":"Effects of MAL-PDT, ingenol mebutate and diclofenac plus hyaluronate gel monitored by high-frequency ultrasound and digital dermoscopy in actinic keratosis - a randomized trial","volume":"34","author":"Arisi","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"issue":"7","key":"10.1016\/j.conctc.2023.101245_bib17","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/jdv.16125","article-title":"Daylight photodynamic therapy for prevention of new actinic keratosis and keratinocyte carcinomas in organ transplants. A cryotherapy-controlled randomized clinical trial","volume":"34","author":"Bernad","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"issue":"6","key":"10.1016\/j.conctc.2023.101245_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/09546634.2019.1687820","article-title":"Efficacy of new class I medical device for actinic keratoses: a randomized controlled prospective study","volume":"32","author":"Veronese","year":"2021","journal-title":"J. Dermatol. Treat."},{"issue":"4","key":"10.1016\/j.conctc.2023.101245_bib19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jaad.2019.09.010","article-title":"A regimen to minimize pain during blue light photodynamic therapy of actinic keratoses: bilaterally controlled, randomized trial of simultaneous versus conventional illumination","volume":"82","author":"Kaw","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.conctc.2023.101245_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pdpdt.2019.05.031","article-title":"Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient randomized trial","volume":"27","author":"Guti\u00e9rrez Garc\u00eda-Rodrigo","year":"2019","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"1","key":"10.1016\/j.conctc.2023.101245_bib21","first-page":"76","article-title":"The conventional protocol vs. a protocol including illumination with a fabric-based biophotonic device (the Phosistos protocol) in photodynamic therapy for actinic keratosis: a randomized, controlled, noninferiority clinical study","volume":"182","author":"Mordon","year":"2020","journal-title":"Br. J. Dermatol."},{"issue":"10","key":"10.1016\/j.conctc.2023.101245_bib22","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJMoa1811850","article-title":"Randomized trial of four treatment approaches for actinic keratosis","volume":"380","author":"Jansen","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.conctc.2023.101245_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/ijd.14363","article-title":"A randomized, open, controlled trial of tretinoin 0.05% cream vs. low-dose oral isotretinoin for the treatment of field cancerization","volume":"58","author":"Ianhez","year":"2019","journal-title":"Int. J. Dermatol."},{"issue":"1","key":"10.1016\/j.conctc.2023.101245_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/03007995.2018.1544887","article-title":"Efficacy of different photoprotection strategies in preventing actinic keratosis new lesions after photodynamic therapy. The ATHENA study: a two-center, randomized, prospective, assessor-blinded pragmatic trial","volume":"35","author":"Pavone","year":"2019","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.conctc.2023.101245_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/bjd.17311","article-title":"5-aminolaevulinic acid nanoemulsion is more effective than methyl-5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double-blind multicentre trial","volume":"181","author":"R\u00e4s\u00e4nen","year":"2019","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.conctc.2023.101245_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjd.17124","article-title":"Topical resiquimod dosing regimens in patients with multiple actinic keratoses: a multicentre, partly placebo-controlled, double-blind clinical trial","volume":"180","author":"Stockfleth","year":"2019","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.conctc.2023.101245_bib27","doi-asserted-by":"crossref","DOI":"10.5070\/D3244039373","article-title":"Randomized and controlled pilot study of the pragmatic use of mobile phone based follow up of actinic keratoses treated with topical 5-fluorouracil","volume":"24","author":"Bosanac","year":"2018","journal-title":"Dermatol. Online J."},{"issue":"4","key":"10.1016\/j.conctc.2023.101245_bib28","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/bjd.16801","article-title":"Patient preferences for topical treatment of actinic keratoses: a discrete-choice experiment","volume":"180","author":"Kopasker","year":"2019","journal-title":"Br. J. Dermatol."},{"issue":"10","key":"10.1016\/j.conctc.2023.101245_bib29","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/jdv.15020","article-title":"Tretinoin (0.05% cream vs. 5% peel) for photoaging and field cancerization of the forearms: randomized, evaluator-blinded, clinical trial","volume":"32","author":"Sumita","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"issue":"3","key":"10.1016\/j.conctc.2023.101245_bib30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jdermsci.2018.02.015","article-title":"Efficacy and safety of topical SR-T100 gel in treating actinic keratosis in Taiwan: a Phase III randomized double-blind vehicle-controlled parallel trial","volume":"90","author":"Yang","year":"2018","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.conctc.2023.101245_bib31","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaad.2018.02.058","article-title":"Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis","volume":"79","author":"Yoon","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.conctc.2023.101245_bib32","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/bjd.16473","article-title":"A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis","volume":"179","author":"Torezan","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"10.1016\/j.conctc.2023.101245_bib33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jamadermatol.2017.0849","article-title":"Effect of expedited microneedle-assisted photodynamic therapy for field treatment of actinic keratoses: a randomized clinical trial","volume":"153","author":"Petukhova","year":"2017","journal-title":"JAMA Dermatol."},{"issue":"10","key":"10.1016\/j.conctc.2023.101245_bib34","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/jdv.14335","article-title":"In vivo microvascular imaging of cutaneous actinic keratosis, Bowen's disease and squamous cell carcinoma using dynamic optical coherence tomography","volume":"31","author":"Themstrup","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"issue":"4","key":"10.1016\/j.conctc.2023.101245_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1684\/ejd.2017.3025","article-title":"Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study","volume":"27","author":"Drago","year":"2017","journal-title":"Eur. J. Dermatol. EJD"},{"issue":"7","key":"10.1016\/j.conctc.2023.101245_bib36","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/09546634.2017.1303568","article-title":"A dose-finding trial with a novel ingenol derivative (ingenol disoxate: LEO 43204) for field treatment of actinic keratosis on full face or 250 cm(2) on the chest","volume":"28","author":"Bourcier","year":"2017","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.conctc.2023.101245_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pdpdt.2017.01.184","article-title":"Efficacy of iontophoresis-assisted ablative fractional laser photodynamic therapy with short incubation time for the treatment of actinic keratosis: 12-month follow-up results of a prospective, randomised, comparative trial","volume":"18","author":"Choi","year":"2017","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"6","key":"10.1016\/j.conctc.2023.101245_bib38","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/bjd.15304","article-title":"A seamless phase I\/II dose-finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp","volume":"176","author":"Weiss","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.conctc.2023.101245_bib39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2340\/00015555-2612","article-title":"Pretreatment with 5-fluorouracil cream enhances the efficacy of daylight-mediated photodynamic therapy for actinic keratosis","volume":"97","author":"Nissen","year":"2017","journal-title":"Acta Derm. Venereol."},{"issue":"1","key":"10.1016\/j.conctc.2023.101245_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12895-017-0064-7","article-title":"Daylight photodynamic therapy versus cryosurgery for the treatment and prophylaxis of actinic keratoses of the face - protocol of a multicenter, prospective, randomized, controlled, two-armed study","volume":"17","author":"Kohl","year":"2017","journal-title":"BMC Dermatol."},{"issue":"2","key":"10.1016\/j.conctc.2023.101245_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-059230","article-title":"Recruitment, consent and retention of participants in randomised controlled trials: a review of trials published in the National Institute for Health Research (NIHR) Journals Library (1997-2020)","volume":"12","author":"Jacques","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.conctc.2023.101245_bib42","unstructured":"Guideline on Computerised Systems and Electronic Data in Clinical Trials."},{"key":"10.1016\/j.conctc.2023.101245_bib43","article-title":"WSJ news exclusive | meta's targeted ad model faces restrictions in Europe","author":"Schechner","year":"2022","journal-title":"Wall St. J."},{"key":"10.1016\/j.conctc.2023.101245_bib44","first-page":"101","article-title":"Teledermatology: its use in the detection and management of actinic keratosis","volume":"vol. 46","author":"Janda","year":"2015"},{"key":"10.1016\/j.conctc.2023.101245_bib45","article-title":"Mild to moderate atopic dermatitis severity can be reliably assessed using smartphone-photographs taken by the patient at home: a validation study","author":"Ali","year":"2022","journal-title":"Skin Res. Technol. Off. J. Int. Soc. Bioeng. Skin ISBS Int. Soc. Digit. Imag. Skin ISDIS Int. Soc. Skin Imag. ISSI"},{"issue":"5","key":"10.1016\/j.conctc.2023.101245_bib46","doi-asserted-by":"crossref","DOI":"10.2196\/24766","article-title":"Remote rating of atopic dermatitis severity using photo-based assessments: proof-of-concept and reliability evaluation","volume":"5","author":"Ali","year":"2021","journal-title":"JMIR Form. Res."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865423001916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865423001916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:09:33Z","timestamp":1762520973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865423001916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":46,"alternative-id":["S2451865423001916"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2023.101245","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accelerating patient recruitment using social media: Early adopter experience from a good clinical practice-monitored randomized controlled phase I\/IIa clinical trial on actinic keratosis","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2023.101245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101245"}}